National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases
- 1 July 1999
- journal article
- guideline
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 45 (7), 1104-1121
- https://doi.org/10.1093/clinchem/45.7.1104
Abstract
The Sixth Conference on the “Standards of Laboratory Practice Series”, sponsored by the National Academy of Clinical Biochemistry (NACB), was held on August 4–5, 1998, at the Annual Meeting of the American Association for Clinical Chemistry, in Chicago, IL. An expert committee was assembled to write recommendations on the use of cardiac markers in coronary artery diseases. The NACB Committee prepared a preliminary draft of the guidelines, made them available on the World Wide Web (www.nacb.org), and distributed them before the presentations. The recommendations were divided into four areas: the use of markers in the triage of patients with chest pain, acute coronary syndromes, clinical applications other than acute myocardial infarction and research, and assay platforms and markers of acute myocardial infarction. The recommendations were revised and subsequently re-presented in part at the “Biomarkers in Acute Cardiac Syndromes Conference”, sponsored by the Jewish Hospital Heart and Lung Institute, Louisville KY, on October 16–17, 1998. This report lists each recommendation, its scientific justification, and a summary of discussions from conference participants and reviewers. Approximately 100 individuals responded to various versions of these recommendations via direct correspondences, telephone calls to Committee members, electronic mail correspondence to the Committee Chairman, or oral questions and comments raised during one of the two conference presentations. Some of the recommendations were changed to reflect the consensus opinion. In cases in which there was no consensus, the Committee included pertinent discussion without necessarily changing the original recommendations. At times, the Committee members felt that although a particular recommendation might not be the current standard of care today, they anticipate that it likely will be adopted in the near future.Keywords
This publication has 91 references indexed in Scilit:
- Value of Troponins in Predicting Therapeutic Efficacy of Abciximab in Patients With Unstable AnginaJournal of the American College of Cardiology, 1998
- An Evaluation of Technologies for Identifying Acute Cardiac Ischemia in the Emergency Department: A Report from a National Heart Attack Alert Program Working GroupAnnals of Emergency Medicine, 1997
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Early detection of acute myocardial infarction in patients presenting with chest pain and nondiagnostic ECGs: Serial CK-MB sampling in the emergency departmentAnnals of Emergency Medicine, 1990
- Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency roomThe American Journal of Cardiology, 1987
- Myoglobin as an early indicator of acute myocardial infarctionAnnals of Emergency Medicine, 1987
- Comparison of ASTK, CK, CK-MB, and LD for the estimation of acute myocardial infarct size in manClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- Factors presaging early recurrent myocardial infarction (“Extension”)The American Journal of Cardiology, 1981
- Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature.Circulation, 1979
- Serum Enzymes with Special Reference to CK-MB Following Coronary Bypass SurgeryScandinavian Journal of Thoracic and Cardiovascular Surgery, 1979